| 1 |
32234756 | TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial. | 2020 Jul 15 |
1 |
| 2 |
29115606 | DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells. | 2018 Jan |
1 |
| 3 |
30249893 | Survivin expression as an independent predictor of overall survival in pancreatic adenocarcinoma. | 2018 Sep |
1 |
| 4 |
27432539 | Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms. | 2017 Sep |
3 |
| 5 |
28099249 | Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration. | 2017 Apr |
1 |
| 6 |
22782330 | The predictive role of p16 deletion, p53 deletion, and polysomy 9 and 17 in pancreatic ductal adenocarcinoma. | 2013 Jan |
1 |
| 7 |
24074410 | EZH2-shRNA-mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarcinoma. | 2013 Oct |
1 |
| 8 |
20018721 | Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. | 2010 Jan 5 |
4 |